Evolution of HER2 expression after neoadjuvant therapy in locally advanced gastric cancer
Weihua Gong(Second Affiliated Hospital of Zhejiang University), Yansong Dong(Second Affiliated Hospital of Zhejiang University), Na Zhong(Maebashi Institute of Technology), Dong Cao(Second Affiliated Hospital of Zhejiang University), Diwen Shou(Second Affiliated Hospital of Guangzhou Medical University), Xinxin Shao(Shandong University of Technology), Yuxin Zhong(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongming Liu(Guiyang Medical University), Han Liang(The University of Texas MD Anderson Cancer Center), Rupeng Zhang(Second Affiliated Hospital of Xi'an Jiaotong University), Haikuo Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Bin Li(Wuhan University), Xuejun Wang(Wuhan University), Yong Liu(Chengdu Medical College), Yiming Lu(Beijing Proteome Research Center), Jingyu Deng(Tianjin Medical University Cancer Institute and Hospital), Yongxing Du(Chinese Academy of Medical Sciences & Peking Union Medical College), Chaojun Hu(Second Affiliated Hospital of Zhejiang University)
Cited by 1
Related Papers
Oncogenic Signaling Pathways in The Cancer Genome Atlas
|Cell|2018|3.4k
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
|Cancer Cell|2017|656
A pan-cancer proteomic perspective on The Cancer Genome Atlas
|Nature Communications|2014|641